Indefinite Delivery Contract SPE2DU25D9327

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), United States Coast Guard, and the U.S. Naval Fleet.

The IDC, which is valid through November 2026, covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across multiple product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract enables the DLA to issue firm fixed-price delivery orders to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The original solicitation, expected to be issued in March 2024, aims to establish multiple Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support, with an estimated total value of $30.3 billion.